Skip to main content

Table 1 Immunohistochemical findings in cervical carcinomas

From: Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases

   HNF-1β ER PR CEA p16 p63 p40 D2-40
   pos neg pos neg pos neg pos neg pos neg pos neg pos neg pos neg
ACA   42 (75%) 14 (25%) 9 (16.1%) 47 (83.9%) 5 (8.9%) 51 (91.1%) 48 (85.7%) 8 (14.3%) 56 (100%) 0 (0%) 4 (7.2%) 52 (92.8%) 2 (3.6%) 54 (96.4%) 0 (0%) 56 (100%)
(56 cases) 3+ 27 (48.2%)   2 (3.6%)   3 (5.4%)   31 (55.4%)   52 (92.9%)   0   0    
  2+ 8 (14.3%)   1 (1.8%)   1 (1.8%)   13 (23.2%)   2 (3.6%)   1 (1.8%)   1 (1.8%)    
  1+ 7 (12.5%)   6 (10.7%)   1 (1.8%)   4 (7.1%)   2 (3.6%)   3 (5.4%)   1 (1.8%)    
SCC   2 (2.35%) 83 (97.65)% 9 (10.6%) 76 (89.4)% 1 (1.2%) 84 (98.8%) 77 (90.6%) 8 (9.4%) 84 (98.8%) 1 (1.2%) 85 (100%) 0 (0%) 85 (100%) 0 (0%) 45 (53.6%) 39 (46.4%)
(85 cases) 3+ 1 (1.2%)   3 (3.5%)   0   13 (15.3%)   83 (97.6%)   83 (97.6%)   83 (97.6%)   15 (17.9%)  
  2+ 1 (1.2%)   2 (2.4)%   0   15 (17.6%)   0   2 (2.4%)   2 (2.4%)   15 (17.9%)  
  1+ 0   4 (4.7%)   1 (1.2%)   49 (57.6%)   1 (1.2%)   0   0   15 (17.9%)  
UC   2 (14.3%) 12 (85.7%) 0 (0%) 14 (100%) 0 (0%) 14 (100%) 8 (57.1%) 6 (42.9%) 14 (100%) 0 (0%) 7 (50%) 7 (50%) 5 (35.7%) 9 (64.3%) 1 (7.1%) 13 (92.9%)
(14 cases) 3+ 1 (7.1%)       1 (7.1%)   13 (92.9%)   4 (28.6%)   4 (28.6%)   0  
  2+ 0       2 (14.3%)   0   1 (7.1%)   0   1 (7.1%)  
  1+ 1 (7.1%)       5 (35.7%)   1 (7.1%)   2 (14.3%)   1 (7.1%)   0  
  1. ACA = adenocarcinomas, SCC = squamous cell carcinomas UC = undifferentiated carcinomas. Pos = positive. Neg = negative. Immunohistochemical results of HNF-1β, estrogen receptors, progesterone receptors, CEA, p63, p40, p16, and D2-40 were semiquantitatively assessed and graded on a four-tier scale based on the percentage of positive cells: 0 = <5%; 1 = 5-29%; 2 = 30-59%; 3 = >60% positive cells.